Im long in Northwest. Im absolutely conviced their IP will be worth over 22 billion after being approved. Im also convinced they will be approved, data is great all that. I have not said anything bad about NWBO. If I have please point me where I have.
I am however not long in Advent or any other private holdings from LP. Also Im not pleased that LP is financing Advent again and building a CDMO/GMP for herself with the help of NWBO funds. I dont see any benefit for NWBO in the ways she is financing Advent.
Since it has become obvious that Advent has been granted the license to operate Swaston as a CDMO/GMP it has been obvious what they are doing. That has nothing to do with NWBO.
There is nothing nefarious about Biogen making antibodies for J&J. It makes business sense for J&J to hire Biogen to do the grunt work while they reap the majority of the profits. Plain and simple business transaction. If J&J wants to pull out and have Genetech manufacture instead, that option is available to them…
100% agree. There is nothing against subcontractors and suppliers, how else could any listed company go by.
Question do you think the CEO of Biogen owns and finances J&J or vice versa?
By the way I have not come around to answer your previous post to me, which I will